111
Participants
Start Date
December 1, 2019
Primary Completion Date
February 28, 2021
Study Completion Date
April 30, 2021
Phenolmicin P3 and Bosexil suppository
The suppository we herein investigated includes different active principles, namely: Bosexil®, that is a vegetal extract derived from the resin of the Boswellia serrata, a plant native to India. It has already been published that the Boswellic acids contained show anti-inflammatory and antioxidant properties in a variety of inflammatory diseases whose physio-pathological pathways are shared with those of prostatitis; phenolmicin P3 is a polyphenolic extract derived from beehive propolis, that also demonstrated anti-inflammatory and antioxidant properties in preclinical reports. It has also been reported to have the ability to create a microenvironment hostile to the reproduction of pathogenic bacteria.
San Carlo di Nancy Hospital, Roma
Lampugnani Farmaceutici S.p.A. (Nerviano, Milan, Italy)
UNKNOWN
San Carlo di Nancy Hospital
OTHER